FindTrial
Sign In

Administration of AMG531 every week after cord blood transplantation

2 trials

Sponsors

Chiba Shigeru, University of Tsukuba Hospital

Conditions

acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), noacute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS), non-Hodgkin lymphoma (NHL)

Phase 1

Prospective study of Romiplostim for rapid platelet recovery after cord blood transplantation, phase 1
Active, not recruitingJPRN-jRCT2031180066
Chiba Shigeruacute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), no
Start: 2019-04-03Target: 6Updated: 2026-06-29

Unknown Phase

Prospective study of ROMiplostim for rapid Platelet recovery after cord blood Transplantation, phase 1
Active, not recruitingJPRN-UMIN000033799
University of Tsukuba Hospitalacute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS), non-Hodgkin lymphoma (NHL)
Start: 2018-01-27Target: 6Updated: 2026-06-29

Related Papers

Safety of romiplostim administered immediately after cord-blood transplantation: a phase 1 trial.
2023-08-172 citations